Feedback / Questions
ADI-001 - Adicet Bio
https://www.businesswire.com/news/home/20250205155838/en/Adicet-Bio-Receives-FDA-Fast-Track-Designation-for-ADI-001-for-the-Treatment-of-Refractory-Systemic-Lupus-Erythematosus-SLE-with-Extrarenal-Involvement
Feb 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next